Published in Glia on November 01, 2010
Wallerian degeneration: gaining perspective on inflammatory events after peripheral nerve injury. J Neuroinflammation (2011) 2.02
Acute injury in the peripheral nervous system triggers an alternative macrophage response. J Neuroinflammation (2012) 1.12
Generating protective immunity against genital herpes. Trends Immunol (2013) 1.00
Repair of the Peripheral Nerve-Remyelination that Works. Brain Sci (2013) 0.94
Opposing effects of Toll-like receptors 2 and 4 on synaptic stability in the spinal cord after peripheral nerve injury. J Neuroinflammation (2012) 0.93
Toll-like receptor 7 rapidly relaxes human airways. Am J Respir Crit Care Med (2013) 0.92
Peripheral nerve repair with cultured schwann cells: getting closer to the clinics. ScientificWorldJournal (2012) 0.87
Genetic Diversity of Toll-Like Receptors and Immunity to M. leprae Infection. J Trop Med (2012) 0.86
The calcium-binding proteins S100A8 and S100A9 initiate the early inflammatory program in injured peripheral nerves. J Biol Chem (2015) 0.85
CCR2 gene deletion and pharmacologic blockade ameliorate a severe murine experimental autoimmune neuritis model of Guillain-Barré syndrome. PLoS One (2014) 0.85
The neuroimmunology of degeneration and regeneration in the peripheral nervous system. Neuroscience (2014) 0.85
Molecules involved in the crosstalk between immune- and peripheral nerve Schwann cells. J Clin Immunol (2014) 0.84
Neurotrauma and inflammation: CNS and PNS responses. Mediators Inflamm (2015) 0.84
Influence of perineurial cells and Toll-like receptors 2 and 9 on Herpes simplex type 1 entry to the central nervous system in rat encephalitis. PLoS One (2010) 0.82
Cross-talk between neural and immune receptors provides a potential mechanism of homeostatic regulation in the gut mucosa. Mucosal Immunol (2014) 0.81
Molecular Mechanisms Involved in Schwann Cell Plasticity. Front Mol Neurosci (2017) 0.80
Knockout of TLR4 and TLR2 impair the nerve regeneration by delayed demyelination but not remyelination. J Biomed Sci (2013) 0.80
Corneal epithelial cells function as surrogate schwann cells for their sensory nerves. Glia (2016) 0.79
Nlrp6 promotes recovery after peripheral nerve injury independently of inflammasomes. J Neuroinflammation (2015) 0.78
Impairment of toll-like receptors 2 and 4 leads to compensatory mechanisms after sciatic nerve axotomy. J Neuroinflammation (2016) 0.78
Temporal Analysis of Gene Expression in the Murine Schwann Cell Lineage and the Acutely Injured Postnatal Nerve. PLoS One (2016) 0.78
TLR7-mediated skin inflammation remotely triggers chemokine expression and leukocyte accumulation in the brain. J Neuroinflammation (2016) 0.77
Evidence of involvement of the mannose receptor in the internalization of Streptococcus pneumoniae by Schwann cells. BMC Microbiol (2014) 0.77
Divergent neuroendocrine responses to localized and systemic inflammation. Semin Immunol (2014) 0.76
Interleukin-17 impedes Schwann cell-mediated myelination. J Neuroinflammation (2014) 0.76
Regulation of microglial activation in stroke. Acta Pharmacol Sin (2017) 0.75
Profiling of the dynamically alteredgene expression in peripheral nerve injury using NGS RNA sequencing technique. Am J Transl Res (2016) 0.75
The Glia Response after Peripheral Nerve Injury: A Comparison between Schwann Cells and Olfactory Ensheathing Cells and Their Uses for Neural Regenerative Therapies. Int J Mol Sci (2017) 0.75
The HMGB1 signaling pathway activates the inflammatory response in Schwann cells. Neural Regen Res (2015) 0.75
The neurochemistry of peripheral nerve regeneration. Indian J Plast Surg (2017) 0.75
Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat Genet (2004) 7.45
DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). Am J Hum Genet (2004) 3.72
Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4. J Exp Med (2003) 3.24
Mutations in the small GTP-ase late endosomal protein RAB7 cause Charcot-Marie-Tooth type 2B neuropathy. Am J Hum Genet (2003) 3.22
Transforming growth factor-beta1 to the bone. Endocr Rev (2005) 3.13
Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathy. Nat Genet (2006) 3.04
Mutant small heat-shock protein 27 causes axonal Charcot-Marie-Tooth disease and distal hereditary motor neuropathy. Nat Genet (2004) 3.00
Hot-spot residue in small heat-shock protein 22 causes distal motor neuropathy. Nat Genet (2004) 2.86
Mutations in the pleckstrin homology domain of dynamin 2 cause dominant intermediate Charcot-Marie-Tooth disease. Nat Genet (2005) 2.79
MFN2 mutation distribution and genotype/phenotype correlation in Charcot-Marie-Tooth type 2. Brain (2006) 2.77
HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1-induced Charcot-Marie-Tooth disease. Nat Med (2011) 2.60
Heterozygous missense mutations in BSCL2 are associated with distal hereditary motor neuropathy and Silver syndrome. Nat Genet (2004) 2.50
Stimulation of Toll-like receptor 3 and 4 induces interleukin-1beta maturation by caspase-8. J Exp Med (2008) 2.40
Axonal neuropathy with optic atrophy is caused by mutations in mitofusin 2. Ann Neurol (2006) 1.98
Loss-of-function mutations in HINT1 cause axonal neuropathy with neuromyotonia. Nat Genet (2012) 1.85
Autoproteolysis of PIDD marks the bifurcation between pro-death caspase-2 and pro-survival NF-kappaB pathway. EMBO J (2006) 1.74
Mutations in a gene encoding a novel SH3/TPR domain protein cause autosomal recessive Charcot-Marie-Tooth type 4C neuropathy. Am J Hum Genet (2003) 1.72
Missense mutations in the copper transporter gene ATP7A cause X-linked distal hereditary motor neuropathy. Am J Hum Genet (2010) 1.70
Mutations in SEPT9 cause hereditary neuralgic amyotrophy. Nat Genet (2005) 1.68
KIF1A, an axonal transporter of synaptic vesicles, is mutated in hereditary sensory and autonomic neuropathy type 2. Am J Hum Genet (2011) 1.66
Mechanisms for nonrecurrent genomic rearrangements associated with CMT1A or HNPP: rare CNVs as a cause for missing heritability. Am J Hum Genet (2010) 1.65
The ubiquitin-editing protein A20 prevents dendritic cell activation, recognition of apoptotic cells, and systemic autoimmunity. Immunity (2011) 1.63
A de novo gain-of-function mutation in SCN11A causes loss of pain perception. Nat Genet (2013) 1.61
Sensory neuropathy with bone destruction due to a mutation in the membrane-shaping atlastin GTPase 3. Brain (2014) 1.55
Mutations in the SPTLC2 subunit of serine palmitoyltransferase cause hereditary sensory and autonomic neuropathy type I. Am J Hum Genet (2010) 1.52
Dominant mutations in the cation channel gene transient receptor potential vanilloid 4 cause an unusual spectrum of neuropathies. Brain (2010) 1.51
Peripheral nerve demyelination caused by a mutant Rho GTPase guanine nucleotide exchange factor, frabin/FGD4. Am J Hum Genet (2007) 1.50
Mutations in FAM134B, encoding a newly identified Golgi protein, cause severe sensory and autonomic neuropathy. Nat Genet (2009) 1.50
Genotype-phenotype analysis in patients with giant axonal neuropathy (GAN). Neuromuscul Disord (2007) 1.49
Genes for hereditary sensory and autonomic neuropathies: a genotype-phenotype correlation. Brain (2009) 1.44
Mechanisms of disease in hereditary sensory and autonomic neuropathies. Nat Rev Neurol (2012) 1.44
Astrocytes regulate GluR2 expression in motor neurons and their vulnerability to excitotoxicity. Proc Natl Acad Sci U S A (2007) 1.42
Pellino proteins are more than scaffold proteins in TLR/IL-1R signalling: a role as novel RING E3-ubiquitin-ligases. FEBS Lett (2006) 1.42
Slowed conduction and thin myelination of peripheral nerves associated with mutant rho Guanine-nucleotide exchange factor 10. Am J Hum Genet (2003) 1.32
Molecular defects in the motor adaptor BICD2 cause proximal spinal muscular atrophy with autosomal-dominant inheritance. Am J Hum Genet (2013) 1.26
Autosomal dominant inherited neuropathies with prominent sensory loss and mutilations: a review. Arch Neurol (2003) 1.22
The paradox of the unfolded protein response in cancer. Anticancer Res (2013) 1.21
Dominant mutations in the tyrosyl-tRNA synthetase gene recapitulate in Drosophila features of human Charcot-Marie-Tooth neuropathy. Proc Natl Acad Sci U S A (2009) 1.21
Ubiquitin: tool and target for intracellular NF-kappaB inhibitors. Trends Immunol (2006) 1.21
Relative contribution of mutations in genes for autosomal dominant distal hereditary motor neuropathies: a genotype-phenotype correlation study. Brain (2008) 1.21
Intracellular trafficking of interleukin-1 receptor I requires Tollip. Curr Biol (2006) 1.18
Exome sequencing identifies a REEP1 mutation involved in distal hereditary motor neuropathy type V. Am J Hum Genet (2012) 1.16
The phenotype of motor neuropathies associated with BSCL2 mutations is broader than Silver syndrome and distal HMN type V. Brain (2004) 1.13
Acute injury in the peripheral nervous system triggers an alternative macrophage response. J Neuroinflammation (2012) 1.12
Small heat-shock protein HSPB1 mutants stabilize microtubules in Charcot-Marie-Tooth neuropathy. J Neurosci (2011) 1.12
Clinical and electrophysiological features in Charcot-Marie-Tooth disease with mutations in the NEFL gene. Arch Neurol (2007) 1.12
Recent advances in hereditary sensory and autonomic neuropathies. Curr Opin Neurol (2006) 1.09
Pellino proteins: novel players in TLR and IL-1R signalling. J Cell Mol Med (2007) 1.08
Periaxin mutations cause a broad spectrum of demyelinating neuropathies. Ann Neurol (2002) 1.08
Mutation scanning the GJB1 gene with high-resolution melting analysis: implications for mutation scanning of genes for Charcot-Marie-Tooth disease. Clin Chem (2007) 1.07
SIMPLE mutation in demyelinating neuropathy and distribution in sciatic nerve. Ann Neurol (2004) 1.03
Identification of novel GDAP1 mutations causing autosomal recessive Charcot-Marie-Tooth disease. Neuromuscul Disord (2003) 1.03
Characterization of two mutations in the SPTLC1 subunit of serine palmitoyltransferase associated with hereditary sensory and autonomic neuropathy type I. Hum Mutat (2011) 1.03
Small heat shock proteins in inherited peripheral neuropathies. Ann Med (2005) 1.02
Increased monomerization of mutant HSPB1 leads to protein hyperactivity in Charcot-Marie-Tooth neuropathy. J Biol Chem (2010) 1.01
A systematic comparison of all mutations in hereditary sensory neuropathy type I (HSAN I) reveals that the G387A mutation is not disease associated. Neurogenetics (2009) 1.01
Molecular genetics of distal hereditary motor neuropathies. Hum Mol Genet (2004) 1.00
Unraveling the genetics of distal hereditary motor neuronopathies. Neuromolecular Med (2006) 0.99
Hereditary sensory neuropathy is caused by a mutation in the delta subunit of the cytosolic chaperonin-containing t-complex peptide-1 (Cct4 ) gene. Hum Mol Genet (2003) 0.97
Phenotypic spectrum of dynamin 2 mutations in Charcot-Marie-Tooth neuropathy. Brain (2009) 0.94
Genetic spectrum of hereditary neuropathies with onset in the first year of life. Brain (2011) 0.93
Reduced penetrance in hereditary motor neuropathy caused by TRPV4 Arg269Cys mutation. J Neurol (2011) 0.93
Dominant intermediate Charcot-Marie-Tooth type C maps to chromosome 1p34-p35. Am J Hum Genet (2003) 0.93
Unraveling the genetic landscape of autosomal recessive Charcot-Marie-Tooth neuropathies using a homozygosity mapping approach. Neurogenetics (2014) 0.92
Novel frameshift and splice site mutations in the neurotrophic tyrosine kinase receptor type 1 gene (NTRK1) associated with hereditary sensory neuropathy type IV. Neuromuscul Disord (2005) 0.91
Genetics of motor neuron disease. Curr Neurol Neurosci Rep (2006) 0.90
A novel homozygous missense mutation in the myotubularin-related protein 2 gene associated with recessive Charcot-Marie-Tooth disease with irregularly folded myelin sheaths. Neuromuscul Disord (2002) 0.89
Animal models and therapeutic prospects for Charcot-Marie-Tooth disease. Ann Neurol (2013) 0.89
Whole-exome sequencing in patients with inherited neuropathies: outcome and challenges. J Neurol (2014) 0.89
Exclusion of serine palmitoyltransferase long chain base subunit 2 (SPTLC2) as a common cause for hereditary sensory neuropathy. Neuromuscul Disord (2002) 0.88
Disease mechanisms in hereditary sensory and autonomic neuropathies. Neurobiol Dis (2005) 0.88
Clinicopathological and genetic study of early-onset demyelinating neuropathy. Brain (2004) 0.88
The UPR and lung disease. Semin Immunopathol (2013) 0.86
The neuroinflammatory role of Schwann cells in disease. Neurobiol Dis (2013) 0.86
Humoral immunodeficiency in congenital insensitivity to pain with anhidrosis. Neurogenetics (2008) 0.85
Neurofilament phosphorylation and their proline-directed kinases in health and disease. J Peripher Nerv Syst (2012) 0.85
Mutant HSPB8 causes motor neuron-specific neurite degeneration. Hum Mol Genet (2010) 0.85
Charcot-Marie-Tooth causing HSPB1 mutations increase Cdk5-mediated phosphorylation of neurofilaments. Acta Neuropathol (2013) 0.85
Experimental Charcot-Marie-Tooth type 1A: a cDNA microarrays analysis. Mol Cell Neurosci (2005) 0.84
Novel mutations in the DYNC1H1 tail domain refine the genetic and clinical spectrum of dyneinopathies. Hum Mutat (2015) 0.84
Recent advances in Charcot-Marie-Tooth disease. Curr Opin Neurol (2014) 0.83
Mutations at Ser331 in the HSN type I gene SPTLC1 are associated with a distinct syndromic phenotype. Eur J Med Genet (2013) 0.83
Genetic variant in the HSPB1 promoter region impairs the HSP27 stress response. Hum Mutat (2007) 0.83
Magnetic resonance imaging findings of leg musculature in Charcot-Marie-Tooth disease type 2 due to dynamin 2 mutation. J Neurol (2008) 0.82
Autosomal-dominant striatal degeneration is caused by a mutation in the phosphodiesterase 8B gene. Am J Hum Genet (2010) 0.82
Mutant HSPB8 causes protein aggregates and a reduced mitochondrial membrane potential in dermal fibroblasts from distal hereditary motor neuropathy patients. Neuromuscul Disord (2012) 0.80
Microtubule dynamics in the peripheral nervous system: A matter of balance. Bioarchitecture (2011) 0.80
HSPB1 facilitates the formation of non-centrosomal microtubules. PLoS One (2013) 0.79
Drosophila as a platform to predict the pathogenicity of novel aminoacyl-tRNA synthetase mutations in CMT. Amino Acids (2011) 0.78
Therapeutic effects of artesunate in hepatocellular carcinoma: repurposing an ancient antimalarial agent. Eur J Gastroenterol Hepatol (2014) 0.78
Search for mutations in the EGR2 corepressor proteins, NAB1 and NAB2, in human peripheral neuropathies. Neurogenetics (2002) 0.78